1.510000 广州, 广州中医药大学研究生院
2.510000 广州, 南部战区总医院输血医学科
Received:03 March 2021,
Revised:2021-04-26,
Published:30 August 2021
移动端阅览
Zixuan GUO, Linying SHI, Yanhui LI, et al. Feasibility of cryopreservation of platelets after virus inactivation[J]. Journal of Third Military Medical University, 2021, 43(16): 1513-1520.
Zixuan GUO, Linying SHI, Yanhui LI, et al. Feasibility of cryopreservation of platelets after virus inactivation[J]. Journal of Third Military Medical University, 2021, 43(16): 1513-1520. DOI: 10.16016/j.1000-5404.202103023.
目的
2
探讨新鲜血小板经核黄素光化学法病毒灭活后进行深低温保存的可行性。
方法
2
采集本院O型健康无偿献血者单采血小板共24 U。实验分为4个组: A为新鲜血小板对照组
B为血小板病毒灭活组(核黄素光化学法灭活处理)
C为新鲜血小板的深低温保存组(-80 ℃保存)
D为病毒灭活血小板的深低温保存组(核黄素光化学法灭活处理后-80 ℃保存)。用150 μmol/L的核黄素结合1.5 J/cm
2
的UVB光源对血小板进行病毒灭活。深低温保存后隔日定义为第1天,取样通过扫描电镜观察血小板超微结构的变化;第1、3、5、7天取样检测血小板数量、质量、功能与代谢相关指标。使用全自动血常规计数仪检测血小板计数(platelet count
PLT)和平均血小板体积(mean platelet volume
MPV),使用比色法观察低渗休克反应能力(hypotonic shock response
HSR)变化;使用Annexin V-FITC和CD62p-PE试剂盒和流式细胞术检测细胞凋亡和激活情况;使用血栓弹力图试验(thromboelastogram test
TEG)检测功能变化,记录最大振幅(maximum amplitude
MA)值;使用速率法检测葡萄糖、乳酸变化。综合评估血小板病毒灭活后深低温保存的可行性。
结果
2
与A组相比较,扫描电镜中B、C、D组血小板伸出伪足数量增多,形状不规则,有明显激活现象;4组MPV均随着保存时间的延长而增大,C、D组明显大于A、B组;4组HSR能力均随着保存时间的延长逐渐降低,C、D组明显不如A、B组;4组的CD62p和Annexin V阳性率中均随着储存时间的延长而增加,D组凋亡与激活现象最明显;组间MA值变化没有统计学差异;A、B组葡萄糖水平均随着储存时间的延长呈明显下降;乳酸含量与葡萄糖含量变化基本相反。综合分析,深低温保存对血小板形态和质量指标的有一定的影响,深低温保存过程对血小板形态和质量指标影响明显大于病毒灭活过程,但其功能和代谢指标变化不明显。
结论
2
核黄素/UVB光化学法病毒灭活的血小板进行深低温保存存在一定可行性。
Objective
2
To investigate the feasibility of deep cryopreservation of fresh platelets after riboflavin photochemical-mediated virus inactivation.
Methods
2
A total of 24 samples of platelets were collected from O-type healthy free blood donors in our general hospital
with each sample of 200 mL. The platelet samples were subsequently divided into 4 groups: fresh platelets control group (group A)
virus inactivated control group (group B)
fresh platelet cryopreservation group (group C
stored at -80 ℃) and cryopreservation of virus inactivated platelets group (group D
riboflavin photochemical-mediated virus inactivation and then stored at -80 ℃). In group B and D
the platelets were treated with riboflavin photochemistry (150 μmol/L riboflavin solution and 1.5 J/cm
2
UVB radiation). The next day after cryopreservation was defined as day 1
and the ultrastructural alterations of platelets were observed with scanning electron microscopy. The quantity
quality
functional and metabolism parameters of platelets were determined on days 1
3
5 and 7
respectively. Platelet count (PLT) and mean platelet volume (MPV) were measured using an automatic blood routine counter; the hypotonic shock response (HSR) of platelets was observed with colorimetry; Annexin V-FITC and CD62p-PE kits and flow cytometry were adopted to examine cell apoptosis and activation; thromboelastogram test (TEG) was conducted to detect the functional changes of platelets for the maximum amplitude (MA) value; and the changes of glucose and lactate content were also tested by rate methods.
Results
2
As compared with group A
the platelets in groups B
C and D were in irregular shape with more parapodia stretched out
which represented an obvious activated state. All groups showed augmented MPV with time prolonging
and the MPV ualues in groups C and D were significant greater than those of groups A and B (
P
<
0.01). The HSR of each group was decreased gradually with elapse of preservation time
with groups C and D presenting more obvious reduction than groups A and B (
P
<
0.01). The positive rates of C
D62p and Annexin V in all groups were elevated over time
and the apoptosis and activation were most notable in group D. The MA value had no significant differences among groups. In addition
the glucose content was declined significantly during preservation
with groups A and B more obvious
while the alteration of lactate was opposite. We found that the morphology and quality of platelets were affected by cryopreservation
and the effect was significantly greater than that caused by virus inactivation. However
its effect on platelet function and metabolism was not distinct.
Conclusion
2
It is feasible for deep cryopreservation of platelets after riboflavin/UVB photochemical-mediated virus inactivation.
WEAVER SC, LECUIT M. Chikungunya virus and the global spread of a mosquito-borne disease[J]. N Engl J Med. 2015, 372(13): 1231-1239. DOI: 10.1056/NEJMra1406035.
FEYS H B, VAN AELST B, COMPERNOLLE V. Biomolecular consequences of platelet pathogen inactivation methods[J]. Transfus Med Rev, 2019, 33(1): 29-34. DOI: 10.1016/j.tmrv.2018.06.002.
CARDO L J, RENTAS F J, KETCHUM L, et al . Pathogen inactivation of Leishmania donovani infantum inplasma and platelet concentrates using riboflavin and ultraviolet light[J ] . Vox Sang, 2006, 90(2): 85-91. DOI: 10.1111/j.1423-0410.2005.00736.x.
KEIL S D, BENGRINE A, BOWEN R, et al . Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemicaltreatment[J ] . Transfusion, 2015, 55(7): 1736-1744. DOI: 10.1111/trf.13030.
REBULLA P, VAGLIO S, BECCARIA F, et al . Clinical effectiveness of platelets in additive solution treated with two commercial pathogen-reduction technologies[J ] . Transfusion, 2017, 57(5): 1171-1183. DOI: 10.1111/trf.14042.
BRECHER ME, B LAJCHMAN MA, YOMTOVIAN R, et al . Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future[J ] . Transfusion. 2013; 53(1): 221-231. DOI: 10.1111/j.1537-2995.2012.03708.x.
BRAATHEN H, SIVERTSEN J, LUNDE THF, et al . In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days[J ] . Transfusion. 2019; 59(8): 2652-2661. DOI: 10.1111/trf.15356.
VALERI C R, RAGNO G, KHURI S. Freezing human platelets with 6 percent dimethylsulfoxide with removal of the supernatant solution before freezing and storage at-80 degrees C without postthaw processing[J]. Transfusion, 2005, 45(12): 1890-1898. DOI: 10.1111/j.1537-2995.2005.00647.x.
SLICHTER S J, DUMONT L J, CANCELAS J A, et al . Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia[J ] . Transfusion, 2018, 58(9): 2129-2138. DOI: 10.1111/trf.14780.
SIX K R, DEVLOO R, COMPERNOLLE V, et al . Impact of cold storage on platelets treated with intercept pathogen inactivation[J ] . Transfusion, 2019, 59(8): 2662-2671. DOI: 10.1111/trf.15398.
MEINKE S, WIKMAN A, GRYFELT G, et al . Cryopreservation of buffy coat-derived platelet concentratesphotochemically treated with amotosalen and UVA light[J ] . Transfusion, 2018, 58(11): 2657-2668. DOI: 10.1111/trf.14905.
WATERS L, PADULA M P, MARKS D C, et al . Cryopreservation of UVC pathogen-inactivated platelets[J ] . Transfusion, 2019, 59(6): 2093-2102. DOI: 10.1111/trf.15204.
JOHNSON L, CAMERON M, WATERS L, et al . The impact of refrigerated storage of UVC pathogen inactivated platelet concentrates on in vitro platelet quality parameters[J ] . Vox Sang, 2019, 114(1): 47-56. DOI: 10.1111/vox.12730.
JOHNSON L, WINTER K M, HARTKOPF-THEIS T, et al . Evaluation of the automated collection and extended storage of apheresis platelets in additive solution[J ] . Transfusion, 2012, 52(3): 503-509. DOI: 10.1016/0006-291x(75)90482-9.
黄成垠, 肖建宇, 蒋妮真, 等. 2种血小板低渗休克反应测定方法的比较研究[J]. 中国输血杂志, 2008, 21(7): 514-516.
HUANG C Y, XIAO J Y, JIANG N Z, et al . Comparative study of two methods for measuring platelet hypotonic shock response[J ] . Chin J Blood Transfus, 2008, 21(7): 514-516.
IRSCH J, LIN L. Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood system TM [J ] . Transfus Med Hemother, 2011, 38(1): 19-31. DOI: 10.1159/000323937.
张爽, 单桂秋, 马静, 等. 短波紫外线灭活血小板中病毒的实验研究[J]. 中国输血杂志, 2016, 29(6): 564-567.
ZHANG S, SHAN G Q, MA J, et al . An experimental study on the virus inactivation in platelet suspension by using short-waveultraviolet[J ] . Chin J Blood Transfus, 2016, 29(6): 564-567.
吴红宜, 单桂秋, 施琳颖, 等. 短波紫外线病毒灭活技术对血小板体外功能影响的实验研究[J]. 中国输血杂志, 2018, 31(2): 127-132.
WU H Y, SHAN G Q, SHI L Y, et al . An experimental study on the function of platelets in vitro after treatment with ultraviolet C light virus inactivation technology[J ] . Chin J Blood Transfus, 2018, 31(2): 127-132..
CORBIN F. Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer[J]. Int J Hematol, 2002, 76 Suppl 2: 253-257. DOI: 10.1007/BF03165125.
HAN X, XU P, DUAN X, et al . High mean platelet volume-to-platelet count ratio as a diagnostic maker for increased risk of liver function damage in pediatric patients with infectious mononucleosis in China[J ] . Exp Ther Med, 2019, 18(6): 4523-4527. DOI: 10.3892/etm.2019.8104.
JOHNSON L, TAN S, WOOD B, et al . Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions[J ] . Transfusion, 2016, 56(7): 1807-1818. DOI: 10.1111/trf.13630.
SARANG Z, SÁGHY T, BUDAI Z, et al . Retinol saturase knock-out mice are characterized by impaired clearance of apoptotic cells and develop mild autoimmunity[J ] . Biomolecules. 2019, 9(11): 737. DOI: 10.3390/biom9110737.
ARTHUR J F, SHEN Y, CHEN Y, et al . Exacerbation of glycoprotein VI-dependent platelet responses in a rhesus monkey model of type 1 diabetes[J ] . J Diabetes Res, 2013, 2013: 370212. DOI: 10.1155/2013/370212.
WHITING D, DINARDO J A. TEG and ROTEM: technology and clinical applications[J]. Am J Hematol. 2014, 89(2): 228-232. DOI: 10.1002/ajh.23599.
JOHNSON L, SCHUBERT P, TAN S, et al . Extended storage and glucose exhaustion are associated with apoptotic changes in platelets stored in additive solution[J ] . Transfusion, 2016, 56(2): 360-368. DOI: 10.1111/trf.13345.
MASTROIANNI M A, LLOHN A H, AKKÖK Ç A, et al . Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets[J ] . Transfus Apher Sci, 2013, 49(2): 285-290. DOI: 10.1016/j.transci.2013.06.009..
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
